Kesler Norman & Wride LLC Makes New $558,000 Investment in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Kesler Norman & Wride LLC purchased a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 1,069 shares of the medical equipment provider's stock, valued at approximately $558,000.

Other hedge funds have also bought and sold shares of the company. M.E. Allison & CO. Inc. purchased a new position in Intuitive Surgical during the fourth quarter worth approximately $449,000. Seilern Investment Management Ltd purchased a new position in Intuitive Surgical during the fourth quarter valued at $82,517,000. Sycomore Asset Management increased its stake in shares of Intuitive Surgical by 27.4% during the fourth quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider's stock worth $9,214,000 after purchasing an additional 4,079 shares in the last quarter. Exome Asset Management LLC raised its holdings in shares of Intuitive Surgical by 16.8% during the third quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider's stock valued at $3,649,000 after acquiring an additional 1,069 shares during the last quarter. Finally, China Universal Asset Management Co. Ltd. boosted its stake in shares of Intuitive Surgical by 5.6% in the fourth quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider's stock worth $5,138,000 after acquiring an additional 525 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company's stock.

Intuitive Surgical Stock Up 2.0 %

ISRG traded up $8.82 during trading hours on Monday, hitting $460.40. 1,820,827 shares of the company's stock were exchanged, compared to its average volume of 1,544,629. Intuitive Surgical, Inc. has a 1-year low of $364.17 and a 1-year high of $616.00. The stock's 50-day moving average is $545.18 and its two-hundred day moving average is $533.00. The stock has a market cap of $163.99 billion, a price-to-earnings ratio of 71.43, a PEG ratio of 5.85 and a beta of 1.55.

Insider Transactions at Intuitive Surgical

In related news, EVP Robert Desantis sold 11,545 shares of the company's stock in a transaction dated Thursday, March 13th. The shares were sold at an average price of $499.22, for a total value of $5,763,494.90. Following the transaction, the executive vice president now directly owns 5,224 shares in the company, valued at approximately $2,607,925.28. This represents a 68.85 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CFO Jamie Samath sold 94 shares of the stock in a transaction that occurred on Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total transaction of $53,684.34. Following the transaction, the chief financial officer now owns 2,630 shares in the company, valued at approximately $1,502,019.30. The trade was a 3.45 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 33,754 shares of company stock worth $17,691,621 in the last 90 days. Corporate insiders own 0.70% of the company's stock.

Analysts Set New Price Targets

Several equities research analysts recently commented on the company. Robert W. Baird cut their price target on Intuitive Surgical from $707.00 to $600.00 and set an "outperform" rating for the company in a report on Tuesday, March 18th. Barclays lifted their target price on shares of Intuitive Surgical from $610.00 to $674.00 in a report on Monday, January 27th. Wells Fargo & Company lifted their price objective on Intuitive Surgical from $630.00 to $687.00 and gave the company an "overweight" rating in a research note on Friday, January 24th. Bernstein Bank lifted their target price on Intuitive Surgical from $655.00 to $700.00 and gave the company an "overweight" rating in a research report on Monday, January 27th. Finally, Royal Bank of Canada increased their price target on shares of Intuitive Surgical from $611.00 to $641.00 in a research report on Monday, January 27th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have given a buy rating to the company's stock. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus target price of $611.86.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.